Industry News
Pharmaceutical Industry News
Melatonin for Sleep: How the Aid Works
The “vampire hormone” can act like a dose of sunset, tricking your body into feeling like it’s time to sleep.
Endo pivots its Dupuytren’s campaign from John Elway to a patient-led pitch
Endo pivots its Dupuytren's campaign from John Elway to a patient-led pitch badams Tue, 01/11/2022 - 12:54
JPM 2022: What FDA crackdown? Novartis oncology chief touts BeiGene PD-1’s global profile
JPM 2022: What FDA crackdown? Novartis oncology chief touts BeiGene PD-1’s global profile aliu Tue, 01/11/2022 - 11:06
China CDMO group ZhenGe Biotech raises $100M in series C financing
China CDMO group ZhenGe Biotech raises $100M in series C financing jkeenan Tue, 01/11/2022 - 09:59
In South Africa, Success Against H.I.V. Offers Hope
A former Africa correspondent, who covered the height of the AIDS epidemic there 15 years ago, finds lessons in the remarkable progress against that virus for our current fight.
JPM 2022: How Novavax plans to be a COVID-19 vaccine force in 2022
JPM 2022: How Novavax plans to be a COVID-19 vaccine force in 2022 fkansteiner Tue, 01/11/2022 - 09:31
Selecta taps Ginkgo to create better capsids for gene therapy delivery
Selecta taps Ginkgo to create better capsids for gene therapy delivery ntaylor Tue, 01/11/2022 - 09:27
Kyowa sells U.S. rights to cancer drug delivery patch to Cumberland
Kyowa sells U.S. rights to cancer drug delivery patch to Cumberland ntaylor Tue, 01/11/2022 - 09:22
South Korea’s SK commits $350M to help build global cell and gene therapy CDMO
South Korea's SK commits $350M to help build global cell and gene therapy CDMO jkeenan Tue, 01/11/2022 - 08:45
JPM 2022: Bluebird CEO sees ‘unfinished business’ with Zynteglo in Europe, but scale-up needed first
JPM 2022: Bluebird CEO sees 'unfinished business' with Zynteglo in Europe, but scale-up needed first aarmstrong Tue, 01/11/2022 - 08:24
JPM22, Day 2: GlaxoSmithKline’s ‘landmark year,’ Novavax’s boosting plans and more
JPM22, Day 2: GlaxoSmithKline's 'landmark year,' Novavax's boosting plans and more esagonowsky Tue, 01/11/2022 - 08:17
JPM22, Day 2: AbbVie’s surprising aesthetics success; Eli Lilly’s tirzepatide plans and more
JPM22, Day 2: AbbVie's surprising aesthetics success; Eli Lilly's tirzepatide plans and more esagonowsky Tue, 01/11/2022 - 08:17
Ogilvy Health poaches Hessel from Harrison & Star as its new chief creative officer
Ogilvy Health poaches Hessel from Harrison & Star as its new chief creative officer badams Tue, 01/11/2022 - 03:29
JPM 2022: Pfizer CEO eyes 50% boost to Paxlovid production—and capacity expansions, too
JPM 2022: Pfizer CEO eyes 50% boost to Paxlovid production—and capacity expansions, too kdunleavy Mon, 01/10/2022 - 17:23
JPM 2022: Bristol Myers plots 3 blockbuster launches to counter Revlimid’s patent cliff
JPM 2022: Bristol Myers plots 3 blockbuster launches to counter Revlimid's patent cliff esagonowsky Mon, 01/10/2022 - 14:27
JPM 2022: Amid underwhelming Aduhelm launch, Biogen supports limited Medicare coverage, exec says
JPM 2022: Amid underwhelming Aduhelm launch, Biogen supports limited Medicare coverage, exec says aliu Mon, 01/10/2022 - 11:27
JPM 2022: New Johnson & Johnson CEO Duato points out 5 pipeline meds that can generate $5B+
JPM 2022: New Johnson & Johnson CEO Duato points out 5 pipeline meds that can generate $5B+ esagonowsky Mon, 01/10/2022 - 11:25
JPM 2022: New Johnson & Johnson CEO Duato points out 5 pipeline meds that can generate $5B-plus
JPM 2022: New Johnson & Johnson CEO Duato points out 5 pipeline meds that can generate $5B-plus esagonowsky Mon, 01/10/2022 - 11:25
2seventy brings in Genevant delivery tech for Novo Nordisk in vivo gene editing project
2seventy brings in Genevant delivery tech for Novo Nordisk in vivo gene editing project ntaylor Mon, 01/10/2022 - 11:19
J&J, following in Sanofi’s footsteps, tasks i2o with oral delivery of large molecules
J&J, following in Sanofi's footsteps, tasks i2o with oral delivery of large molecules ntaylor Mon, 01/10/2022 - 11:17